MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-75-0024035
Shrijan Pharmaceuticals Private Limited
Shrijan Pharmaceuticals Private Limited - trading in Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.74 Cr
▲ 11% YoY
Net profit · FY 2024
₹74,147
Net margin 0.4%
EBITDA · FY 2024
₹10.85 Lakh
EBITDA margin 6.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.65 Lakh
Issued & subscribed
Open charges
₹35 Lakh
Secured borrowings
Company age
25 yrs
Est. 2001
Directors on board
2
As per MCA filings
About Shrijan Pharmaceuticals Private Limited
Data last updated:
Shrijan Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 20 June 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24232UP2001PTC026096. Its GSTIN is 09AAHCS1963N1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.65 Lakh. It is led by directors Rajani Singh and Ajeet Pratap Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sh – 5/12 – N – 4 – 2 – Alaxmanpur Shivpur Varanasi, Uttar Pradesh, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.74 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹74,147 (net margin 0.4%) and EBITDA of ₹10.85 Lakh (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹35 Lakh on record.
Shrijan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0024035). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232UP2001PTC026096
Registration Number 026096
Incorporation Date 20 June 2001
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-75-0024035
Key People
Rajani Singh Director Ajeet Pratap Singh Director Recognitions & Rankings of Shrijan Pharmaceuticals
Contact details
Shrijan Pharmaceuticals Private Limited's registered office is in Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSh – 5/12 – N – 4 – 2 – Alaxmanpur Shivpur Varanasi, Uttar Pradesh, India
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Shrijan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Shrijan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Shrijan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shrijan Pharmaceuticals Private Limited, buy the company report.
Financials of Shrijan Pharmaceuticals Private Limited
FY 2025 filings availableShrijan Pharmaceuticals Private Limited reported revenue of ₹1.74 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹1.74 Cr ▲ 11%
Net profit · FY 2024
₹74,147 margin 0.4%
EBITDA · FY 2024
₹10.85 Lakh margin 6.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 23%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 59%
5 years · compounded
▲ 33%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 11% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74,147 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shrijan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shrijan Pharmaceuticals Private Limited
Shrijan Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajani Singh | Director | 20 Jun 2001 | 25 Years 4 Months | Current |
| Ajeet Pratap Singh | Director | 20 Jun 2001 | 25 Years 4 Months | Current |
Peer comparison
Shrijan Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stoicure Pharmaceuticals Private Limited | ₹1.76 Cr (FY 2024) | 432.0% | Ahmedabad, Gujarat, India | |||
| Vin Arx Pharmaceuticals Private Limited | ₹1.75 Cr (FY 2025) | 197.0% | Panchkula, Haryana, India | |||
| Shrijan Pharmaceuticals Private Limitedthis company | ₹1.74 Cr (FY 2024) | ₹74,147 | 0.4% | 11.0% | Uttar Pradesh, India | |
| Sandmartin Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Aanyas Pharmaceuticals India Private Limited | ₹1.73 Cr (FY 2024) | 4.0% | Raipur, Chhattisgarh, India |
To see the full peer comparison of Shrijan Pharmaceuticals Private Limited, buy the company report.
Auditor
Shrijan Pharmaceuticals Private Limited is audited by K. K. Singh & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. K. Singh & Associates | FY 2017 | 76097 |
Shareholding
The shareholding of Shrijan Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Shrijan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹35 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 2025 | 101052955 | Others | ₹35 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Shrijan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shrijan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shrijan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCS1963N1ZQ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shrijan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Shrijan Pharmaceuticals Private Limited has 2 board changes on record since 2001: 2 appointments. The latest: Ajeet Pratap Singh was appointed as Director on 20 Jun 2001.
AGM
Shrijan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Shrijan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Others amounted to Rs. 35.00 Lakh with Charge ID 101052955 was registered on 05 Feb 2025.
Appointed
Ajeet Pratap Singh was appointed as Director.
Appointed
Rajani Singh was appointed as Director.
Incorporation
20 Jun 2001
Shrijan Pharmaceuticals Private Limited was registered on 20 Jun 2001 with Roc Uttar Pradesh I & aged 25 years 4 months as per MCA records.
Frequently asked questions
Shrijan Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 20 June 2001 (25+ years old) and is registered under CIN U24232UP2001PTC026096.
Shrijan Pharmaceuticals has 2 current directors:
- Rajani Singh - Director
- Ajeet Pratap Singh - Director
The latest financial statements of Shrijan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shrijan Pharmaceuticals is 09AAHCS1963N1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Shrijan Pharmaceuticals is U24232UP2001PTC026096. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shrijan Pharmaceuticals was incorporated on 20 June 2001, making it 25+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Shrijan Pharmaceuticals by revenue are Stoicure Pharmaceuticals Private Limited, Vin Arx Pharmaceuticals Private Limited, Sandmartin Pharmaceuticals Private Limited, Aanyas Pharmaceuticals India Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajeet Pratap Singh was appointed as Director on 20 Jun 2001. Rajani Singh was appointed as Director on 20 Jun 2001.
Yes, Shrijan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0024035).
The registered office of Shrijan Pharmaceuticals is at Sh – 512 – N – 4 – 2 – Alaxmanpur Shivpur Varanasi, Uttar Pradesh, India.
Shrijan Pharmaceuticals operates in the trading industry, in the other wholesale segment.